Hamid Farahani

9PUBLICATIONS
38CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Gene expression (incl. microarray and other genome-wide approaches)Food properties (incl. characteristics and health benefits)NeurogeneticsNutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 30, 2025
Impact of genetic variation in the human leptin gene promoter on metabolic dysfunction-associated steatotic liver disease risk.

Fatemeh Ghasemi, Mitra Rostami, Zahra Ourang

|Oct 18, 2024
Association of IRS1 gene Pro512Ala polymorphism with nonalcoholic fatty liver disease.

Asadollah Asadi, Mitra Rostami, Radmehr Shafiee

|Jul 24, 2024
The rs1862513 promoter variant of resistin gene influences susceptibility to nonalcoholic fatty liver disease.

Shadi Nouri, Mahsa Navari, Radmehr Shafiee

|May 18, 2023
A visfatin gene promoter polymorphism (rs1319501) is associated with susceptibility to nonalcoholic fatty liver disease.

Touraj Mahmoudi, Donya Ghorbani, Gholamreza Rezamand

|Dec 14, 2022
RESISTIN GENE POLYMORPHISM AND NONALCOHOLIC FATTY LIVER DISEASE RISK.

Seidamir Pasha Tabaeian, Touraj Mahmoudi, Gholamreza Rezamand

|Oct 27, 2021
CIRCULATING GHRELIN LEVELS AND SUSCEPTIBILITY TO COLORECTAL CÂNCER.

Asadollah Asadi, Hamid Farahani, Touraj Mahmoudi

Pageof 2